Clinical trial
The Molecular Characterization of Multiple Myeloma at Relapse
NCT00639054 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Molecular Characterization of Multiple Myeloma at Relapse
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- December 31, 2014
- Enrollment
- 134 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.